156 related articles for article (PubMed ID: 36958421)
1. Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study.
Cheng AYY; Goldenberg R; Krawchenko I; Tytus R; Hahn J; Liu A; Golden S; Millson B; Harris S
Can J Diabetes; 2023 Jul; 47(5):398-404. PubMed ID: 36958421
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional Study.
Cheng AYY; Harris S; Krawchenko I; Tytus R; Hahn J; Liu A; Millson B; Golden S; Goldenberg R
Can J Diabetes; 2023 Jun; 47(4):345-351. PubMed ID: 36828737
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With Attainment of Glycemic Targets Among Adults With Type 1 and Type 2 Diabetes in Canada: A Cross-sectional Study Using Primary and Specialty Care Electronic Medical Record Data.
Weisman A; Brown R; Chu L; Aronson R; Perkins BA
Can J Diabetes; 2024 Feb; 48(1):44-52.e5. PubMed ID: 37717631
[TBL] [Abstract][Full Text] [Related]
4. Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis.
De Clifford-Faugère G; Nguena Nguefack HL; Choinière M; Pagé MG; Blais L; Guénette L; Dorais M; Lacasse A
Int J Environ Res Public Health; 2023 Aug; 20(15):. PubMed ID: 37569033
[TBL] [Abstract][Full Text] [Related]
5. Influence of the COVID-19 pandemic on regular clinic visits and medication prescriptions among people with diabetes: Retrospective cohort analysis of health care claims.
Maeda T; Nishi T; Harada M; Tanno K; Nishiya N; Asayama K; Okuda N; Sugiyama D; Yatsuya H; Okayama A; Arima H
Medicine (Baltimore); 2022 Jul; 101(29):e29458. PubMed ID: 35866768
[TBL] [Abstract][Full Text] [Related]
6. Population Trends of New Prescriptions for Antihyperglycemics and Antihypertensives Between 2014 and 2022.
Yu AYX; Austin PC; Jackevicius CA; Chu A; Holodinsky JK; Hill MD; Kamal N; Kumar M; Lee DS; Vyas MV; Joundi RA; Khan NA; Kapral MK; McNaughton CD
J Am Heart Assoc; 2024 Apr; 13(8):e034118. PubMed ID: 38563374
[TBL] [Abstract][Full Text] [Related]
7. Trends in Delirium and New Antipsychotic and Benzodiazepine Use Among Hospitalized Older Adults Before and After the Onset of the COVID-19 Pandemic.
Reppas-Rindlisbacher C; Boblitz A; Fowler RA; Lapointe-Shaw L; Sheehan KA; Stukel TA; Rochon PA
JAMA Netw Open; 2023 Aug; 6(8):e2327750. PubMed ID: 37548976
[TBL] [Abstract][Full Text] [Related]
8. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
9. Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study.
Manski-Nankervis JA; Thuraisingam S; Sluggett JK; Kilov G; Furler J; O'Neal D; Jenkins A
BMC Fam Pract; 2019 Feb; 20(1):29. PubMed ID: 30777033
[TBL] [Abstract][Full Text] [Related]
10. Drug utilization patterns before and during COVID-19 pandemic in Manitoba, Canada: A population-based study.
Aboulatta L; Peymani P; Vaccaro C; Leong C; Kowalec K; Delaney J; Falk J; Alessi-Severini S; Aloud B; Eltonsy S
PLoS One; 2022; 17(11):e0278072. PubMed ID: 36441676
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic Prescriptions During the COVID-19 Pandemic Among U.S. Children and Adolescents Receiving Mental Health Services.
Amill-Rosario A; Lee H; Zhang C; dosReis S
J Child Adolesc Psychopharmacol; 2022 Sep; 32(7):408-414. PubMed ID: 36067121
[No Abstract] [Full Text] [Related]
12. A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns.
Secrest MH; Azoulay L; Dahl M; Clemens KK; Durand M; Hu N; Targownik L; Turin TC; Dormuth CR; Filion KB
Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():86-92. PubMed ID: 31464069
[TBL] [Abstract][Full Text] [Related]
13. Impact of the COVID-19 pandemic on the glycemic control in people with diabetes mellitus: A retrospective cohort study.
Ohkuma K; Sawada M; Aihara M; Doi S; Sekine R; Usami S; Ohe K; Kubota N; Yamauchi T
J Diabetes Investig; 2023 Aug; 14(8):985-993. PubMed ID: 37118898
[TBL] [Abstract][Full Text] [Related]
14. Trends in the Incidence of New-Onset Anorexia Nervosa and Atypical Anorexia Nervosa Among Youth During the COVID-19 Pandemic in Canada.
Agostino H; Burstein B; Moubayed D; Taddeo D; Grady R; Vyver E; Dimitropoulos G; Dominic A; Coelho JS
JAMA Netw Open; 2021 Dec; 4(12):e2137395. PubMed ID: 34874405
[TBL] [Abstract][Full Text] [Related]
15. Time-series analysis of recent antihyperglycemic medication prescribing trends for a diverse sample of Medicare enrollees with type 2 diabetes mellitus in an integrated health system.
Miller MJ; DiNucci AJ; Jalalzai R; Rabinovich N; Roblin DW
Am J Health Syst Pharm; 2022 Jun; 79(12):950-959. PubMed ID: 35176753
[TBL] [Abstract][Full Text] [Related]
16. Prescription Patterns and the Cost of Antihyperglycemic Drugs in Patients With Type 2 Diabetes Mellitus in Germany.
Jacob L; von Vultee C; Kostev K
J Diabetes Sci Technol; 2017 Jan; 11(1):123-127. PubMed ID: 27402240
[TBL] [Abstract][Full Text] [Related]
17. A comparison between different patient groups for diabetes management during phases of the COVID-19 pandemic: a retrospective cohort study in Ontario, Canada.
Senthinathan A; Tu K; Stephenson E; O'Neill B; Lipscombe L; Ji C; Butt DA; Apajee J; Train A; Crampton N
BMC Prim Care; 2024 Jan; 25(1):43. PubMed ID: 38280984
[TBL] [Abstract][Full Text] [Related]
18. Association of personalised care plans with monitoring and control of clinical outcomes, prescription of medication and utilisation of primary care services in patients with type 2 diabetes: an observational real-world study.
Mikkola I; Morgan S; Winell K; Jokelainen J; Frittitta L; Heikkala E; Hagnäs M
Scand J Prim Health Care; 2022 Mar; 40(1):39-47. PubMed ID: 35148662
[TBL] [Abstract][Full Text] [Related]
19. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database.
Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L
Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367
[TBL] [Abstract][Full Text] [Related]
20. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
